Compare HTCR & HKPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HTCR | HKPD |
|---|---|---|
| Founded | 2009 | 2016 |
| Country | Japan | Hong Kong |
| Employees | N/A | N/A |
| Industry | EDP Services | Other Pharmaceuticals |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.7M | 10.6M |
| IPO Year | 2022 | 2025 |
| Metric | HTCR | HKPD |
|---|---|---|
| Price | $0.33 | $0.74 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 197.6K | 65.9K |
| Earning Date | 11-18-2025 | 08-14-2025 |
| Dividend Yield | ★ 41.27% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $16,189,136.00 | ★ $20,313,818.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $3.52 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 21.72 |
| 52 Week Low | $0.22 | $0.68 |
| 52 Week High | $3.38 | $3.79 |
| Indicator | HTCR | HKPD |
|---|---|---|
| Relative Strength Index (RSI) | 31.80 | 35.07 |
| Support Level | $0.31 | $0.68 |
| Resistance Level | $0.38 | $0.77 |
| Average True Range (ATR) | 0.04 | 0.05 |
| MACD | 0.00 | 0.01 |
| Stochastic Oscillator | 46.22 | 39.00 |
HeartCore Enterprises Inc is a software development company. The company provides software through two business units. The first business unit includes a customer experience management business. The customer experience management platform includes marketing, sales, service, and content management systems, as well as other tools and integrations that enable companies to attract and engage customers throughout the customer experience. It also provides education, services and support to help customers be successful with the CXM Platform. The second business unit, DX division, is a digital transformation business that provides customers with robotics process automation, process mining, and task mining to accelerate the digital transformation of enterprises.
Hong Kong Pharma Digital Technology Holdings Ltd operates in two main categories: (i) OTC pharmaceutical cross-border e-commerce supply chain services, conducted through its Hong Kong subsidiary, Joint Cross Border, which it refers to as the Supply Chain Services division, and (ii) OTC pharmaceutical cross-border procurement and distribution, conducted through its Hong Kong subsidiary, V-Alliance, which it referred to as the Procurement and Distribution division. Based in Hong Kong, Joint Cross Border has established itself as a provider of third-party supply chain services in Mainland China's OTC pharmaceutical cross-border e-commerce market.